The FDA approved an expanded indication for Enbrel (etanercept) to inhibit the structural damage of active arthritis in patients with psoriatic arthritis, reported Amgen Inc. and Wyeth Pharmaceuticals.
4 For 4 Sessions With Raj Chovatiya, MD, PhD, Present Range of Dermatology Challenges and Opportunities
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
Overview of Maui Derm NP+PA Fall 2023
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
The Retirement “Red Zone”: What You Need to Know to Score Financially
POLL: Are You Attending Maui Derm NP+PA Fall 2023?
2 Clarke Drive Cranbury, NJ 08512